Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Maria DeBernardi is active.

Publication


Featured researches published by Maria DeBernardi.


MedChemComm | 2012

Non-iminosugar glucocerebrosidase small molecule chaperones

Juan J. Marugan; Wenwei Huang; Omid Motabar; Wei Zheng; Jingbo Xiao; Samarjit Patnaik; Noel Southall; Wendy Westbroek; Wendy A. Lea; Anton Simeonov; Ehud Goldin; Maria DeBernardi; Ellen Sidransky

Small molecule chaperones are a promising therapeutic approach for the Lysosomal Storage Disorders (LSDs). Here, we report the discovery of a new series of non-iminosugar glucocerebrosidase inhibitors with chaperone capacity, and describe their structure activity relationship (SAR), selectivity, cell activity phamacokinetics.


Methods in Enzymology | 2006

High‐Content Kinetic Calcium Imaging in Drug‐Sensitive and Drug‐Resistant Human Breast Cancer Cells

Maria DeBernardi; Gary Brooker

Intracellular calcium (Ca2+) is involved in the regulation of a variety of biological functions in cancer cells, including growth inhibition, tumor invasiveness, and drug resistance. To gain insight into the possible role played by Ca2+ in the development of drug resistance in breast cancer, we performed a comparative high-content analysis of the intracellular Ca2+ dynamics in drug-sensitive human breast cancer MCF-7 cells and five drug-resistant, MCF-7-derived clonal cell lines. Fura-2 single cell ratiometric fluorescence microscopy was used to monitor real-time quantitative changes in cytosolic-free Ca2+ concentration ( [Ca2+]i ) upon addition of phosphoinositol-coupled receptor agonists. While the magnitude and the onset kinetics of the [Ca2+]i rise were similar in drug-sensitive and drug-resistant cell lines, the decay kinetics of the [Ca2+]i increase was found to be consistently slower in drug-resistant than drug-sensitive cells. Such a delay in reestablishing homeostatic [Ca2+]i persisted in the absence of extracellular Ca2+ and was independent of the expression or function of specific drug efflux pumps associated with drug resistance. Moreover, intracellular Ca2+ pools releasable by phosphoinositol-coupled receptor agonists or thapsigargin appeared to be differentially shared in drug-sensitive and drug-resistant cells. In light of the clinical relevance that drug resistance has in the treatment of cancer, the molecular and biochemical relationship between alterations in Ca2+ dynamics and drug resistance demands to be further investigated and tested in a wider array of cell types. Automated microscopy will help greatly in this pursuit by facilitating both sample imaging and data analysis, thus allowing high-content as well as high-throughput screening of large sample sets. A protocol for studying [Ca2+]i kinetics with a commercially available automated imaging platform is described.


Archive | 2002

Methods for diagnosing drug-resistant cancer cells or for identifying chemotherapeutic agents by measuring anomalous intracellular ion and/or second messenger dynamics

Maria DeBernardi; Gary Brooker


Archive | 2011

Identification of Modulators of the N370S Mutant Form of Glucocerebrosidase as a Potential Therapy for Gaucher Disease - Chemotype 2

Omid Motabar; Wenwei Huang; Juan J. Marugan; Noel Southall; Maria DeBernardi; Wei Zheng; Ellen Sidransky


Archive | 2011

Table 4, Analogs with sulfonamide aromatic modifications having a thiophene at the two position

Omid Motabar; Wenwei Huang; Juan J. Marugan; Noel Southall; Maria DeBernardi; Wei Zheng; Ellen Sidransky


Archive | 2011

Table 9, Analogs with modifications at the molecular core

Omid Motabar; Wenwei Huang; Juan J. Marugan; Noel Southall; Maria DeBernardi; Wei Zheng; Ellen Sidransky


Archive | 2011

Table 11, Concentrations of CID9893924 in plasma, brain, liver and tail; intraperitoneal administration twice at a 12 hour interval of CID9893924 at 20mg/kg dose in male Swiss Albino Mice (mean and SD)

Omid Motabar; Wenwei Huang; Juan J. Marugan; Noel Southall; Maria DeBernardi; Wei Zheng; Ellen Sidransky


Archive | 2011

Table 12, Comparison of GC inhibitory activities with Somatostatin receptor sst4 activity

Omid Motabar; Wenwei Huang; Juan J. Marugan; Noel Southall; Maria DeBernardi; Wei Zheng; Ellen Sidransky


Archive | 2011

Table 5, A continuation of Table 4 - analogs with sulfonamide aromatic modifications having a thiophene at the two position

Omid Motabar; Wenwei Huang; Juan J. Marugan; Noel Southall; Maria DeBernardi; Wei Zheng; Ellen Sidransky


Archive | 2011

Scheme 7, Additional modifications at the 2 position

Omid Motabar; Wenwei Huang; Juan J. Marugan; Noel Southall; Maria DeBernardi; Wei Zheng; Ellen Sidransky

Collaboration


Dive into the Maria DeBernardi's collaboration.

Top Co-Authors

Avatar

Ellen Sidransky

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Juan J. Marugan

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Noel Southall

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Omid Motabar

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Wenwei Huang

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Gary Brooker

Johns Hopkins University

View shared research outputs
Top Co-Authors

Avatar

Wei Zheng

Government of the United States of America

View shared research outputs
Top Co-Authors

Avatar

Anton Simeonov

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Ehud Goldin

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Jingbo Xiao

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge